MedTrace Logo

Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

NCT00242983 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: Studying quality-of-life in patients undergoing cancer treatment may help identify the intermediate and long-term effects of treatment on patients with cancer.

PURPOSE: This clinical trial is studying quality of life in patients who are receiving either vinorelbine, gemcitabine, and docetaxel or paclitaxel and carboplatin for advanced non-small cell lung cancer.

Conditions

Interventions

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Hospital Organization Kinki-chuo Chest Medical Center

    lead OTHER

Principal Investigators

  • Masaaki Kawahara, MD · National Hospital Organization Osaka National Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00242983 on ClinicalTrials.gov